Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | LN75D | — |
expired dose of Menveo was administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number LN75D, expiry date 30-SEP-2025) for prophylaxis. On 16-OCT-2025, the patient received Menveo. On 16-OCT-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose of Menveo was administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 23-OCT-2025 A medical assistant had called to report the administration of an expired dose of Menveo (1 vial) to a patient. The reporter had enquired if the patient needed to be revaccinated.